Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma

Leukemia

Volumn 26, Issue 1, 2012, Pages 180-183

  Martin Perez D ^a   Vargiu, P ^a   Montes Moreno, S ^a   Leon E A ^a   Rodriguez Pinilla S M ^a   Lisio, L D ^a   Martinez N ^a   Rodriguez R ^b   Mollejo, M ^b   Castellvi, J ^c   Pisano, D G ^a   Sanchez Beato M ^a   Piris, M A ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MICRORNA; PROTEIN BART17; PROTEIN BART3; PROTEIN BART7; PROTEIN BART9; PROTEIN BCL 6; PROTEIN LMP1; PROTEIN LMP2A; UNCLASSIFIED DRUG; VIRUS PROTEIN;

3' UNTRANSLATED REGION; BINDING SITE; CLINICAL ARTICLE; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE CLUSTER; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICRORNAS;

EID: 84856739043     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.189     Document Type: Letter

References (13)

1. Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008.
2. Perez-Rosado A, Artiga M, Vargiu P, Sanchez-Aguilera A, Alvarez-Barrientos A, Piris M. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. J Pathol 2008; 214: 498-507. (Pubitemid 351340570)
3. Carbone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 1997; 150: 155-165. (Pubitemid 27027106)
4. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J et al. Identification of virus-encoded microRNAs. Science 2004; 304: 734-736. (Pubitemid 38560879)
5. Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11: 375-383.
6. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51-62. (Pubitemid 34874618)
7. Vasanwala FH, Kusam S, Toney LM, Dent AL. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 2002; 169: 1922-1929. (Pubitemid 34857655)
8. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ et al. NF-kappaB is essential for the progression of KSHV-and EBV-infected lymphomas in vivo. Blood 2006; 107: 3295-3302.
9. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B celllike diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861-1874. (Pubitemid 34028664)
10. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389-399.
11. Cahir McFarland ED, Izumi KM, Mosialos G. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 1999; 18: 6959-6964.
12. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM et al. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 2004; 78: 4108-4119. (Pubitemid 38437217)
13. Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T. The IKK2/NF-{appa}B pathway suppresses MYC-induced lymphomagenesis. Blood 2009; 114: 2448-2458.